DAFNA Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $15.2M | Sell |
|
|||||
|
2023
Q3 | $8.94M | Buy |
|
|||||
|
2023
Q2 | $9.15M | Sell |
|
|||||
|
2023
Q1 | $14.3M | Buy |
|
|||||
|
2022
Q4 | $14.2M | Buy |
|
|||||
|
2022
Q3 | $6.5M | Sell |
|
|||||
|
2022
Q2 | $7.85M | Sell |
|
|||||
|
2022
Q1 | $10.4M | Buy |
|
|||||
|
2021
Q4 | $9.49M | Sell |
|
|||||
|
2021
Q3 | $9.12M | Buy |
|
|||||
|
2021
Q2 | $6.04M | Buy |
|
|||||
|
2021
Q1 | $5.77M | Buy |
|
|||||
|
2020
Q4 | $1.69M | Buy |
|
|||||
|
2020
Q3 | $714K | Hold |
|
|||||
|
2020
Q2 | $1.03M | Buy |
|
|||||
|
2020
Q1 | $449K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $183K | Buy |
|
|||||
|
2019
Q2 | $200K | Buy |
|